The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-10-14
DOI
10.1002/jcp.27619
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
- (2016) Yang Zhao et al. Oncotarget
- N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression
- (2015) Stephanie Holst et al. MOLECULAR & CELLULAR PROTEOMICS
- The prognostic value of CD44 expression in gastric cancer: A meta-Analysis
- (2014) Yansu Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
- (2014) Xueyuan Cao et al. BMC GASTROENTEROLOGY
- Altered Tumor-Cell Glycosylation Promotes Metastasis
- (2014) Irina Häuselmann et al. Frontiers in Oncology
- CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer
- (2013) SEIYA SAITO et al. ONCOLOGY REPORTS
- CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2013) Shicai Chen et al. PLoS One
- Prognostic Value of CD166 Expression in Cancers of the Digestive System: A Systematic Review and Meta-Analysis
- (2013) Chao Ni et al. PLoS One
- CD133: A cancer stem cells marker, is used in colorectal cancers
- (2013) Fei Ren WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
- (2012) Ke Wang et al. BMC CANCER
- Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
- (2012) K. Kemper et al. CLINICAL CANCER RESEARCH
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- Colorectal Cancer Stem Cells
- (2012) Aristides G. Vaiopoulos et al. STEM CELLS
- CD133+, CD166+CD44+, and CD24+CD44+ Phenotypes Fail to Reliably Identify Cell Populations with Cancer Stem Cell Functional Features in Established Human Colorectal Cancer Cell Lines
- (2012) Manuele Giuseppe Muraro et al. Stem Cells Translational Medicine
- One renegade cancer stem cell?
- (2011) Tijana Borovski et al. CELL CYCLE
- Lessons from common markers of tumor-initiating cells in solid cancers
- (2011) Olivier Gires CELLULAR AND MOLECULAR LIFE SCIENCES
- Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles-a role of the endocytic-exocytic pathway
- (2011) Nicola Bauer et al. EMBO Molecular Medicine
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- CD133 and membrane microdomains: Old facets for future hypotheses
- (2011) Christine A Fargeas WORLD JOURNAL OF GASTROENTEROLOGY
- Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells
- (2010) Yongqiang Liao et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer
- (2010) A Lugli et al. BRITISH JOURNAL OF CANCER
- The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
- (2010) K. Kemper et al. CANCER RESEARCH
- Isolation and Propagation of a Human CD133- Colon Tumor-Derived Cell Line with Tumorigenic and Angiogenic Properties
- (2010) Nalú Navarro-Alvarez et al. CELL TRANSPLANTATION
- Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
- (2010) Christina H. Stuelten et al. STEM CELLS
- Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis
- (2010) Ryan Morrison et al. Journal of Oncology
- CD133 and nuclear β-catenin: The marker combination to detect high risk cases of low stage colorectal cancer
- (2009) David Horst et al. EUROPEAN JOURNAL OF CANCER
- Targeting CD133 antigen in cancer
- (2009) Gabriella Ferrandina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116
- (2009) Claudia Dittfeld et al. RADIOTHERAPY AND ONCOLOGY
- CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells
- (2008) Naotsugu Haraguchi et al. ANNALS OF SURGICAL ONCOLOGY
- N-Glycans in cancer progression
- (2008) K. S Lau et al. GLYCOBIOLOGY
- Characterization of a subpopulation of colon cancer cells with stem cell-like properties
- (2008) Peter Chu et al. INTERNATIONAL JOURNAL OF CANCER
- Colonic and colorectal cancer stem cells: progress in the search for putative biomarkers
- (2008) Naomi D. Willis et al. JOURNAL OF ANATOMY
- Cancer stem cell markers in common cancers – therapeutic implications
- (2008) Thomas Klonisch et al. TRENDS IN MOLECULAR MEDICINE
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now